1-20 of 25
Alison Gulbis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Addition of Inotuzumab Ozogamicin to the Conditioning Regimen of Allogeneic Stem Cell Transplantation (allo-SCT) for Relapsed CD22 (+) Lymphoid Malignancies: Long-Term Survival Results

Issa F. Khouri, Kamal Alzahrani, Alison Gulbis, Koji Sasaki, Nitin Jain, Nicholas J. Short, Tapan M. Kadia, May Daher, MD, Hind Rafei, Jin S Im, David Marin, Amanda L. Olson, Uday R. Popat, Muzaffar H. Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A. Srour, Partow Kebriaei, Elizabeth J. Shpall, Hagop M. Kantarjian, Richard E. Champlin, Elias Jabbour
Journal: Blood
Blood (2023) 142 (Supplement 1): 233.
https://doi.org/10.1182/blood-2023-181880
Published: 2023
Journal Articles

High Efficacy of the PARP Inhibitor Olaparib Combined with High-Dose Chemotherapy and Autologous Stem-Cell Transplant for Refractory Lymphomas

Yago Nieto, Benigno C Valdez, Peter F Thall, Jeremy L. Ramdial, Samer A Srour, Chitra Hosing, Neeraj Saini, Amin M Alousi, Muzaffar H Qazilbash, Uday R Popat, Alison Gulbis, Terri Lynn Shigle, Roland Bassett, Maria Guillermo-Pacheco, Celina Ledesma, Paolo Strati, Sairah Ahmed, Raphael Steiner, Jason Westin, Ranjit Nair, Swaminathan P. Iyer, Richard E Champlin, Elizabeth J Shpall, Borje S Andersson
Journal: Blood
Blood (2022) 140 (Supplement 1): 1183–1184.
https://doi.org/10.1182/blood-2022-156121
Published: 2022
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Venetoclax in Patients with AML/MDS: Prospective Phase II Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Alison Gulbis, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Marina Konopleva, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2879.
https://doi.org/10.1182/blood-2021-146253
Published: 2021
Journal Articles

Bacterial Prophylaxis in Patients with Acute Gvhd; Who Is at Risk for Bloodstream Infections?

Whitney Wallis, Alison Gulbis, Tao Wang, Karen Chen, Carrie Lynn Kitko, Margaret L. MacMillan, Joseph Pidala, Marcie L. Riches, Stephen R. Spellman, Mukta Arora, Amin M. Alousi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2870.
https://doi.org/10.1182/blood-2021-148890
Published: 2021
Journal Articles

A Randomized Study of Pretransplant Conditioning Therapy for AML/MDS with Fludarabine ± Clofarabine and Once Daily IV Busulfan with Allogeneic Hematopoietic Transplantation for AML and MDS

Borje S. Andersson, MD, PhD, Peter Thall, Benigno C. Valdez, PhD, Junsheng Ma, MS, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Alison Gulbis, Chitra Hosing, MD, Roy B. Jones, MD PhD, Jitesh Kawedia, BPharm, Partow Kebriaei, MD, Steven M. Kornblau, MD, Alan Myers, PharmD, PhD RPh, Betul Oran, MDMS, Katayoun Rezvani, MD PhD, Nina Shah, MD, Elizabeth J. Shpall, MD, Simrit Parmar, MD, MSCI, Uday R. Popat, MD, Yago Nieto, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-142680
Published: 2020
Journal Articles

Lower Risk of Graft Versus Host Disease after Exposure to Checkpoint Inhibitors with the Use of Post-Transplant Cyclophosphamide Prophylaxis

Chantal Saberian, MD, Noha Abdel-Wahab, Ala Abudayyeh, MD, Hind Rafei, MD, Jacinth Joseph, MD, May Daher, Stephen K. Gruschkus, PhD MPH, Cristina Knape, Laura Whited, Alison Gulbis, Megan Marcotulli, Gabriela Rondon, Uday R. Popat, MD, Rohtesh S. Mehta, MDMPH,MS, Marina Konopleva, MD PhD, Betul Oran, MDMS, Maro Ohanian, DO, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, MD, Amin M. Alousi, MD, Naval Daver, MD, Richard E. Champlin, MD, Adi Diab, MD, Gheath Alatrash
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-139614
Published: 2020
Journal Articles

Maintenance Therapy with Ipilimumab Plus Lenalidomide after Autologous Stem Cell Transplantation for Patients with Lymphoma

Issa F. Khouri, MD, Denái R. Milton, MS, Celina Ledesma, Elias Jabbour, MD, Qaiser Bashir, Jin S. Im, Luis Fayad, Hun Ju Lee, MD, Ranjit Nair, Loretta J. Nastoupil, MD, Felipe Samaniego, MD, Swami P. Iyer, MD, Christopher Flowers, MDMS, Richard E. Champlin, MD, Padmanee Sharma, Alison Gulbis
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–11.
https://doi.org/10.1182/blood-2020-138778
Published: 2020
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation with or without Inotuzumab Ozogamicin for Lymphoid Malignancies

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Alison Gulbis, Celina Ledesma, Nitin Jain, MD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Paolo Anderlini, Qaiser Bashir, MD, May Daher, Partow Kebriaei, MD, David Marin, Rohtesh Mehta, Uday R. Popat, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Jin S. Im, Luis Fayad, Ranjit Nair, MD, Swaminathan P Iyer, MD, Paolo Strati, MD, Felipe Samaniego, MD, Loretta J. Nastoupil, MD, Christopher Flowers, MDMS, Gabriela Rondon, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–12.
https://doi.org/10.1182/blood-2020-141985
Published: 2020
Journal Articles

Autologous Vs. Allogeneic Stem Cell Transplantation in Double-Expressor Lymphoma

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Celina Ledesma, Paolo Anderlini, Qaiser Bashir, May Daher, Swami P. Iyer, MD, David Marin, Rohtesh Mehta, Amanda L. Olson, Uday R. Popat, MD, Felipe Samaniego, MD, Muzaffar H. Qazilbash, MD, Jin S. Im, Gabriela Rondon, Richard E. Champlin, MD, Alison Gulbis, Ken H. Young
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-138741
Published: 2020
Journal Articles

Risk of Gvhd and Survival in Patients with Acute Leukemia Who Were Bridged to Allogeneic Stem Cell Transplantation (alloSCT) with Venetoclax- Based Therapy

Akash Mukherjee, Denái R. Milton, MS, Elias Jabbour, MD, Naval Daver, MD, Alison Gulbis, Celina Ledesma, Marina Konopleva, MD PhD, Courtney D. DiNardo, MD MSCE, Farhad Ravandi, MBBS, Tapan M. Kadia, MD, Gheath Alatrash, Amin M. Alousi, MD, May Daher, David Marin, Amanda L. Olson, Betul Oran, MDMS, Partow Kebriaei, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Uday R. Popat, MD, Jin S. Im, Rohtesh Mehta, Gabriela Rondon, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-137097
Published: 2020
Journal Articles

Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience

Yago Nieto, MD, Stephen K. Gruschkus, PhD MPH, Roy B. Jones, MD PhD, Benigno C. Valdez, PhD, Melissa Timmons, PA-C, Chitra Hosing, MD, Paolo Anderlini, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Amin M. Alousi, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Jin S. Im, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD, Alison Gulbis, Terri Lynn Shigle, PharmD, Kris Michael Mahadeo, MD, Sajad Khazal, MD, Issa F. Khouri, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Hun Lee, MD, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Swaminathan P Iyer, MD, Ranjit Nair, MD, Simrit Parmar, MD, MSCI, Branko Cuglievan, MD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Borje S. Andersson, MD, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-139880
Published: 2020
Journal Articles

Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantation (ASCT) for Patients (pts) with Relapsed Follicular Lymphoma (FL)

Issa F. Khouri, MD, Denái R. Milton, Celina Ledesma, Loretta J. Nastoupil, MD MSc, Elias Jabbour, MD, Paolo Anderlini, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, May Daher, MD, Luis E. Fayad, MD, Jin S Im, MD PhD, Swaminathan P. Iyer, MD, David Marin, MD, Rohtesh S. Mehta, MD, Jeffrey J. Molldrem, Amanda L. Olson, MD, Betul Oran, MDMS, Uday Popat, MD, Muzaffar Qazilbash, Samer Srour, Felipe Samaniego, MD, Gabriela Rondon, MD, L. Jeffrey Medeiros, MD, Alison Gulbis, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 322.
https://doi.org/10.1182/blood-2019-124590
Published: 2019
Journal Articles

Post-Transplant Cyclophosphamide (PT-Cy) Based Haploidentical Cell Transplantation (Haplo) Versus Rabbit Anti-Thymocyte Globulin (r-ATG) Based HLA Matched Unrelated Donor (MUD) Transplantation in Patients (pts) with Relapsed/Refractory Lymphoma

Akash Mukherjee, MD, Denái R. Milton, Alison Gulbis, Celina Ledesma, Elias Jabbour, MD, Amin M. Alousi, MD, Qaiser Bashir, MBBS, May Daher, MD, Betul Oran, MDMS, Amanda L. Olson, MD, David Marin, MD, Samer Srour, Partow Kebriaei, MD, Rohtesh S. Mehta, MD, Kathie P Nemeth, BS, Uday Popat, MD, Jin S Im, MD PhD, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4530.
https://doi.org/10.1182/blood-2019-125876
Published: 2019
Journal Articles

Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation

Yingjun Wang, Ken H. Young, MD PhD, Denái R. Milton, Celina Ledesma, Elias Jabbour, MD, Zijun Yidan Xu-Monette, PhD, Jeffrey J. Molldrem, Paolo Anderlini, Amin M. Alousi, MD, Qaiser Bashir, MBBS, May Daher, MD, Luis E. Fayad, MD, Swaminathan P. Iyer, MD, Partow Kebriaei, MD, David Marin, MD, Rohtesh S. Mehta, MD, Amanda L. Olson, MD, Uday Popat, MD, Felipe Samaniego, MD, Jason R. Westin, MD, Muzaffar H. Qazilbash, MD, Jin S Im, MD PhD, Gabriela Rondon, MD, Alison Gulbis, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2021.
https://doi.org/10.1182/blood-2019-126719
Published: 2019
Journal Articles

Influence of the Intensity of the Conditioning Regimens on the Risks of Gvhd in Patients Receiving Rituximab Prophylaxis during Allogeneic Stem Cell Transplantation (alloSCT)

Issa F. Khouri, Denái R. Milton, Celina Ledesma, Elias J. Jabbour, MD, Gheath Alatrash, DO, PhD, Paolo Anderlini, MD, Amin M. Alousi, MD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Sharon Hymes, BS, MD, David Marin, MD, Jeffrey J. Molldrem, MD, Amanda L. Olson, MD, Betul Oran, MDMS, Uday Popat, MD, Muzaffar H. Qazilbash, MD, Gabriela Rondon, MD, Richard E Champlin, MD, Alison Gulbis
Journal: Blood
Blood (2018) 132 (Supplement 1): 4584.
https://doi.org/10.1182/blood-2018-99-112990
Published: 2018
Journal Articles

Durable Responses with Ipilimumab Plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies

Issa F. Khouri, Jorge A Borin Scutti, Denái R. Milton, Courtney Nicholas, Mariana Pineda, Elias J. Jabbour, MD, Roland L. Bassett, Jr., Shalini S Yadav, Luis M Vence, James P Allison, PhD, Alison Gulbis, Padmanee Sharma, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4585.
https://doi.org/10.1182/blood-2018-99-117814
Published: 2018
Journal Articles

Durability Results of Non-Myeloablative (NMA) Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed Follicular Lymphoma: 17- Year Experience

Issa F. Khouri, Denái R. Milton, Celina Ledesma, William D Erwin, MS, Elias J. Jabbour, MD, Gheath Alatrash, DO, PhD, Paolo Anderlini, MD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Jin S Im, MD PhD, David Marin, MD, Rohtesh S. Mehta, MD MPH, MS, Jeffrey J. Molldrem, MD, Amanda L. Olson, MD, Betul Oran, MD MS, Uday Popat, MD, Muzaffar H. Qazilbash, MD, Gabriela Rondon, MD, Richard E Champlin, MD, L. Jeffrey Medeiros, MD, Alison Gulbis
Journal: Blood
Blood (2018) 132 (Supplement 1): 4651.
https://doi.org/10.1182/blood-2018-99-117767
Published: 2018
Journal Articles

Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation

Clinical Trials & Observations
Stefan O. Ciurea, Jolie R. Schafer, Roland Bassett, Cecele J. Denman, Kai Cao, Dana Willis, Gabriela Rondon, Julianne Chen, Doris Soebbing, Indreshpal Kaur, Alison Gulbis, Sairah Ahmed, Katayoun Rezvani, Elizabeth J. Shpall, Dean A. Lee, Richard E. Champlin
Journal: Blood
Blood (2017) 130 (16): 1857–1868.
https://doi.org/10.1182/blood-2017-05-785659
Published: 2017
Includes: Supplemental data
Journal Articles

Assessment of Incidence Toxoplasma Gondii Infection and Outcomes in Allogeneic Stem Cell Patients

Sairah Ahmed, MD, Elizabeth J Shpall, MD, Alison Gulbis, Roy Jones, Charles S. Martinez, Gabriela Rondon, MD, Katayoun Rezvani, Betul Oran, MD, Amanda Olson, Nina Shah, Simrit Parmar, Uday R. Popat, MD, Amin M. Alousi, MD, Yago Nieto, Chitra M. Hosing, Qaiser Bashir, Partow Kebriaei, Muzaffar H. Qazilbash, Richard E. Champlin, Victor E. Mulanovich
Journal: Blood
Blood (2014) 124 (21): 1187.
https://doi.org/10.1182/blood.V124.21.1187.1187
Published: 2014
Journal Articles

BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD

Issa F. Khouri, Wei Wei, Martin Korbling, Francesco Turturro, Sairah Ahmed, Amin Alousi, Paolo Anderlini, Stefan Ciurea, Elias Jabbour, Betul Oran, Uday R. Popat, Gabriela Rondon, Roland L. Bassett, Jr, Alison Gulbis
Journal: Blood
Blood (2014) 124 (14): 2306–2312.
https://doi.org/10.1182/blood-2014-07-587519
Published: 2014